Therapix Biosciences (TRPX) Reports Q2 Loss of $0.61
Tweet
Share
E-mailGet Alerts TRPX Hot Sheet
Join SI Premium – FREE
Therapix Biosciences (NASDAQ: TRPX) reported Q2 EPS of ($0.61).
For earnings history and earnings-related data on Therapix Biosciences (TRPX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
- XP Inc eyes US banking license as next business step
- Tesla to launch Cybercab in Austin this month - report
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
